摘要
目的:对银黄口服液的处方配比及提取物精制方法进行研究。方法:以体外抗金黄色葡萄球菌效果为指标对银黄口服液的处方配比、金银花提取物精制方法及精制后与黄芩提取物的最佳比例进行考察。结果与结论:体外抑菌试验表明,现行银黄口服液标准中金银花提取物与黄芩提取物的处方配比量的有待改进,金银花提取物可用乙酸乙酯进行萃取精制,其与黄芩提取物的最佳配比为现行标准的5倍。
Objective:To dicucss the rationality of prescription compatibility and the refining method of extracts from Yinhuang oral liquid.Method:Appoint the effect of vitro anti-Staphylococcus aureus as the evaluating indicator to determinate the prescription allocated proportion of Yinhuang oral liquid,the method to refine extracts from Lonicerae Japonicae Flos and the optimum proportion of refined material to extracts from Scutellariae Radix.Result and conclusion:The result of vitro anti-staphylococcus aureus showed:In the present standard of the Yinhuang oral liquid,the prescription allocated proportion need to be improved.The extract from Lonicerae Japonicae Flos can be refined by ethyl acetate,and the optimum proportion of refined material to extracts from Scutellariae Radix is 5 times than the present standard.
出处
《中国实验方剂学杂志》
CAS
北大核心
2011年第18期43-46,共4页
Chinese Journal of Experimental Traditional Medical Formulae
关键词
银黄口服液
处方再评价
金银花提取物
黄芩提取物
金黄色葡萄球菌
Yinhuang oral liquid
prescription re-evaluation
extracts from Lonicerae Japonicae Flos
extracts from Scutellariae Radix
Staphylococcus aureus